85246561 - GLYCOTOPE

Information

• Trademark
• 85246561

• Source

• Serial Number

  85246561

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 18, 2011
  13 years ago

• Transaction Date

  August 21, 2015
  9 years ago

• Status Date

  August 21, 2015
  9 years ago

• Published for Opposition Date

  November 01, 2011
  12 years ago

• Location Date

  August 21, 2015
  9 years ago

• Status Code

  602

• Current Location

  LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  ORTIGA PALMER, RAMONA

• Attorney Docket Number

  S15199

  Attorney Name

  Leigh Ann Lindquist

  Law Office Assigned Location Code

  M80

• Owners

  • Glycotope GmbH

Case File Statements

• CC0000: Color is not claimed as a feature of the mark.
• DM0000: The mark consists of the word "GLYCOTOPE" in which the "O"s are shaded and have a vertical line above and below.
• GS0011: Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins; unprocessed plastics; fertilising preparations; fire extinguishing compositions; tempering substances and soldering chemicals; chemical substances for fermenting and preserving food stuffs; tanning agents for use in the manufacture of leather; adhesives used in industry; bacteria and cell preparations and elements, fragments, fractions and lysates thereof, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment, bacteria and cell preparations for use in expression of engineered or glycosylated proteins and peptides; preparations containing bacteria and cells, except for medical or veterinary purposes, namely, for use in protein production, food manufacturing, scientific research, waste water treatment; biological preparations for laboratories, except for medical or veterinary purposes, namely, for use in bacterial and cell engineering, cultivation, harvesting, protein production; chemical preparations for analysis in laboratories, namely, preparations for protein, peptide, engineered proteins and peptides, glycoproteins, glycosylation, antibody or antigen analysis, preparations comprising antibody reagents used for the detection of antigens; chemical preparations for scientific purposes; chemical reagents except for medical or veterinary purposes and biological reagents in the nature of reagents for use in protein production, bacterial and cell engineering, cultivation and harvesting, probes for detecting and analyzing molecules in protein or nucleotide arrays, except for medical or veterinary purposes; diagnostic preparations, except for medical or veterinary purposes; enzymes, proteins and related preparations for industrial purposes, namely, engineered proteins, glycosylated proteins, antibodies, enzymes for use in glycosylation, enzyme substrates, proteins used in the manufacture of cosmetics, beverages, food products and food supplements; ferments for chemical purposes, namely, yeast, bacterium, mold, or enzyme, that causes fermentation; in-vitro diagnostic reagents, other than for medical purposes, namely, for use in biochemistry, clinical chemistry and microbiology; carbohydrates for use in the manufacture of food or nutraceuticals; cultures of microorganisms, other than for medical or veterinary use, and cells and elements, fragments, fractions and lysates thereof, other than for medical or veterinary purposes, namely, cultures of microorganisms or cells other than for medical and veterinary use, microorganism or cell cultures for use in protein production, food manufacturing, scientific research, waste water treatment, cultures of microorganisms or cells for use in expression of proteins and peptides; expression systems for proteins and peptides comprising cells, particularly human cells and microorganisms, suitable for expressing engineered or glycosylated proteins or peptides, or capable of providing optimized glycosylation activity; milk ferments for chemical purposes
• GS0051: Pharmaceutical preparations and veterinary preparations for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; sanitary preparations for medical purposes; dietetic sugar for medical use; food for babies; medical plasters; materials for dressings, namely, wound dressings, burn dressings, and surgery dressings; materials for dental filling, namely, fillings for teeth, and impression materials for dental purposes; disinfectants for hygienic purposes, medical instruments, sanitary purposes; preparations for destroying vermin; fungicides, herbicides; adjuvants for medical purposes; medicines for human purposes and veterinary purposes for pets and livestock, namely, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological preparations for medical purposes; dietetic food adapted for medical purposes; enzymes, proteins, antibodies, cells, microorganisms as well as fragments, fractions, elements and lysates thereof for medical purposes for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine, and as nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; vaccines; nutritional supplements, namely, carbohydrates for medical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; cultures of microorganisms for medical or veterinary purposes; cultures of cells, particularly human cells for medical or veterinary purposes; medicinal drinks; microorganisms, cells and preparations containing elements, fragments, fractions and lysates of microorganisms or cells for medical and veterinary purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; biological therapeutics, namely, therapeutics containing cells, microorganisms, proteins, glycoproteins, peptides, glycopeptides or modified or conjugated versions thereof, all for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; milk ferments for pharmaceutical purposes, namely, for prophylaxis or treatment of cancer, inflammatory diseases, autoimmune diseases, allergies, cardiovascular diseases, infectious diseases, neurological diseases, gastrointestinal diseases, and for use in wound healing, formation of blood and tissue and reproduction medicine; nutritional additives and nutritional supplement additives all for medical purposes for use in foods and dietary supplements for human consumption; nutrients for medical purposes, namely, nutritional supplements; sugar and carbohydrates for medical purposes, namely, therapeutically and prophylactically active sugar and carbohydrates, dietetic sugar and carbohydrates, sugar and carbohydrate replacements
• GS0421: Medical laboratories, namely, consumer-authorized clinical laboratory testing services that report results directly to the patient; scientific and technological services and research and designer services relating thereto, namely, in the field of biotechnology, protein production, glycosylation, optimization of protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; industrial analysis and research services in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; design and development of computer hardware and software; biological research; services of a chemical or biological laboratory; technical surveying; conducting scientific surveys in the field of biotechnology, bacterial and cell engineering, protein production, glycosylation; scientific research and development, namely, in the field of bacteriology, cytology, antibody technology, chemistry, immunology, cosmetics of expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, particularly for proteins and peptides; quality control for others; research and development of new products; research and development of new technologies for others in the field of biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; technical and scientific consultancy in relation to biotechnology, protein production, glycosylation, protein, antibody and enzyme activity, bacteria and cell engineering, cultivation and harvesting; research and development in the field of glycomics, expression systems in the nature of production or glycosylation of proteins, peptides, antibodies and enzymes, development and improvement of cells, cell lines and microorganisms, antibody-engineering, optimized biological therapeutics, nutraceuticals, food and nutritional supplements; scientific research, quality control, technical consultancy and product development in the field of proteins, antibodies, microorganisms and cells; scientific research and development in the field of microorganisms and cells
• GS0441: Medical services and veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services, namely, vermin extermination for agriculture, pest control services for agriculture, horticulture or forestry; pharmaceutical advice; performance of medical services featuring clinical examinations; nutrition counseling; health consultancy

Case File Event Statements

• 8/21/2015 - 9 years ago

  54 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 8/21/2015 - 9 years ago

  53 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 1/31/2015 - 9 years ago

  52 - ASSIGNED TO EXAMINER Type: DOCK

• 1/23/2015 - 9 years ago

  51 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/23/2015 - 9 years ago

  50 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/23/2015 - 9 years ago

  49 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/22/2015 - 9 years ago

  48 - ASSIGNED TO EXAMINER Type: DOCK

• 1/22/2015 - 9 years ago

  47 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/22/2015 - 9 years ago

  46 - ASSIGNED TO EXAMINER Type: DOCK

• 12/30/2014 - 9 years ago

  45 - CASE RETURNED TO EXAMINATION Type: OTHE

• 12/29/2014 - 9 years ago

  44 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN

• 11/26/2014 - 9 years ago

  43 - ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED Type: ATRQ

• 11/26/2014 - 9 years ago

  42 - PETITION TO DIRECTOR - CHANGE BASIS - GRANTED Type: PCBG

• 11/19/2014 - 9 years ago

  41 - ASSIGNED TO PETITION STAFF Type: APET

• 11/10/2014 - 9 years ago

  40 - TEAS PETITION TO AMEND BASIS RECEIVED Type: TPAD

• 6/6/2014 - 10 years ago

  39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/5/2014 - 10 years ago

  38 - EXTENSION 5 GRANTED Type: EX5G

• 6/4/2014 - 10 years ago

  37 - EXTENSION 5 FILED Type: EXT5

• 6/4/2014 - 10 years ago

  36 - TEAS EXTENSION RECEIVED Type: EEXT

• 4/10/2014 - 10 years ago

  35 - ASSIGNED TO EXAMINER Type: DOCK

• 12/10/2013 - 10 years ago

  34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/9/2013 - 10 years ago

  33 - EXTENSION 4 GRANTED Type: EX4G

• 12/5/2013 - 10 years ago

  32 - EXTENSION 4 FILED Type: EXT4

• 12/5/2013 - 10 years ago

  31 - TEAS EXTENSION RECEIVED Type: EEXT

• 7/18/2013 - 11 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 7/17/2013 - 11 years ago

  29 - EXTENSION 3 GRANTED Type: EX3G

• 6/19/2013 - 11 years ago

  28 - EXTENSION 3 FILED Type: EXT3

• 7/15/2013 - 11 years ago

  27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 6/19/2013 - 11 years ago

  26 - TEAS EXTENSION RECEIVED Type: EEXT

• 12/22/2012 - 11 years ago

  25 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/20/2012 - 11 years ago

  24 - EXTENSION 2 GRANTED Type: EX2G

• 12/20/2012 - 11 years ago

  23 - EXTENSION 2 FILED Type: EXT2

• 12/20/2012 - 11 years ago

  22 - TEAS EXTENSION RECEIVED Type: EEXT

• 6/23/2012 - 12 years ago

  21 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/21/2012 - 12 years ago

  20 - EXTENSION 1 GRANTED Type: EX1G

• 6/21/2012 - 12 years ago

  19 - EXTENSION 1 FILED Type: EXT1

• 6/21/2012 - 12 years ago

  18 - TEAS EXTENSION RECEIVED Type: EEXT

• 12/27/2011 - 12 years ago

  17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 11/1/2011 - 12 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 11/1/2011 - 12 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 9/27/2011 - 12 years ago

  14 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 9/26/2011 - 12 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 9/24/2011 - 13 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/24/2011 - 13 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/6/2011 - 13 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/1/2011 - 13 years ago

  9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/1/2011 - 13 years ago

  8 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/1/2011 - 13 years ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/19/2011 - 13 years ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 5/12/2011 - 13 years ago

  5 - APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED Type: AMPX

• 5/4/2011 - 13 years ago

  4 - ASSIGNED TO LIE Type: ALIE

• 4/27/2011 - 13 years ago

  3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI

• 2/24/2011 - 13 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/22/2011 - 13 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP